Provision of Haemophilia Advanced Therapy Medicinal Product (ATMP) Treatment Hub

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), is inviting suitably qualified and experienced providers to respond to this invitation to tender (ITT) exercise to commission haemophilia Advanced Therapy Medicinal Product (ATMP) treatment hubs. The haemophilia ATMP treatment hub allocation model is as follows: Lot 1 - One site to cover the NHS England population in the East of England Lot 2 - Two sites to cover the NHS England population in London Lot 3 - One site to cover the NHS England population in the Midlands Lot 4 - One site to cover the NHS England population in the North East of England and Yorkshire Lot 5 - One site to cover the NHS England population in the North West of England Lot 6 - One site to cover the NHS England population in the South East of England Lot 7 - One site to cover the NHS England population in the South West of England Please note that providers must be located in the defined geographical catchment area(s) that they are interested in providing services to. Atamis (Health Family) reference: C153405